Health
Moffitt researchers reveal why some ovarian cancer patients evolve better than others – News-Medical.Net
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed….
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective therapies for advanced disease and recurrence. Immunotherapies hold promise for many types of cancer; however, studies have shown that patients with ovarian cancer do not have strong responses to existing drugs.
In a new article published in Nature, Moffitt Cancer Center…
-
General17 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General20 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News19 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
Business23 hours agoThese ASX 200 shares could rise 55% to 65%